High performance liquid chromatography method for detecting ethylparaben and BHT (butylated hydroxytoluene) in tretinoin cream

Through high-performance liquid chromatography analysis method, the separation and quantitative detection of hydroxyethyl hydroxyphenyl ester and BHT in retinoic acid cream is achieved through the use of specific chromatographic columns and mobile phase conditions, combined with sample pretreatment, and the non-existent technology has been solved. The problem of effectively detecting these two components meets many performance requirements for detection.

CN119064481APending Publication Date: 2024-12-03SHANGHAI RETINUO PHARM TECH CO LTD +1
View PDF 0 Cites 1 Cited by

Patent Information

Application Number
CN202310643281.1
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2023-06-01
Publication Date
2024-12-03

AI Technical Summary

Technical Problem

The prior art has failed to effectively provide a quality control method for detecting ethyl hydroxyphenyl ester and BHT in retinoic acid cream, and it is rare to detect these two components simultaneously.

Method used

High performance liquid chromatography analysis method was used, including using an Agilent ZORBAX Eclipse XDB Phenyl 4.6×150mm chromatography column, 0.02%-0.2% aqueous formic acid solution and 0.02%-0.2% acetonitrile formic acid as mobile phase, column temperature was 30-40℃, flow rate was 0.8- 1.2 ml/min, detection wavelength 280±5nm elution procedure, combined with sample pretreatment methods such as ultrasonic extraction and dilution, to achieve separation and quantitative analysis of hydroxyphenyl ethyl ester and BHT.

Benefits of technology

This method can meet the requirements of specificity, linearity, sensitivity, accuracy, repeatability and durability, and realize efficient qualitative and quantitative detection of ethyl hydroxyphenyl ester and BHT in retinoic acid cream, providing a basis for quality control.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure BDA0004262356990000031
    Figure BDA0004262356990000031
  • Figure BDA0004262356990000041
    Figure BDA0004262356990000041
  • Figure BDA0004262356990000061
    Figure BDA0004262356990000061
Patent Text Reader

Abstract

The invention provides a high performance liquid chromatography analysis method for detecting ethylparaben and BHT (butylated hydroxytoluene) in tretinoin cream. According to the method, the tretinoin can be separated from the ethylparaben and the BHT, a basis is provided for quality control of the ethylparaben and the BHT in the tretinoin cream, and experiments prove that the method can meet the requirements of specificity, linearity, sensitivity, accuracy, repeatability and durability.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention relates to the field of chemical analysis, and in particular to a high performance liquid chromatography analysis method for detecting ethylparaben and BHT in tretinoin cream. Background Art

[0002] Retinoic acid cream is a common drug for preventing abnormal skin keratinization and induced cell differentiation. Retinoic acid is the active ingredient, ethylparaben is an antibacterial agent, and 2,6-di-tert-butyl-4-methylphenol (BHT) is an antioxidant.

[0003] As an antimicrobial preservative, ethylparaben is widely used in cosmetics, food and pharmaceutical preparations. It can be used alone or in combination with other hydroxyphenyl esters or antimicrobial agents. It is one of the most commonly used antimicrobial preservatives in cosmetics.

[0004] In 2004, Darbre's research report detected five common paraben ingredients in breast cancer tissue, which aroused the concern of the international cosmetics industry about the safety of this type of preservatives. A large number of experimental studies have shown that this type of preservatives may have estrogenic activity. Rats exposed to (consuming) this type of preservatives for a long time showed a trend of reduced hormone secretion, endocrine system disorders, and affected the normal development of reproductive organs. The European Consumer Safety Scientific Committee SCCS recommends a maximum usage of 0.4% for parabens. In addition, for methylparaben, ethylparaben and propylparaben, WHO stipulates an acceptable daily total intake of 10 mg per kilogram of body weight.

[0005] The safety assessment report on BHT in the International Journal of Toxicology stated that butylated hydroxytoluene can penetrate the skin, but the amount absorbed is small. Butylated hydroxytoluene is not carcinogenic and has no obvious irritation, sensitization or photosensitization effects, but high levels can be toxic to the liver, kidneys, and lungs. Usually, the amount of butylated hydroxytoluene added to cosmetics is around 0.2%. According to the U.S. Cosmetic Ingredient Review (CIR), the maximum amount of butylated hydroxytoluene in cosmetics is 0.5%. The safety assessment opinion on butylated hydroxytoluene published by the European Union Consumer Safety Scientific Committee SCCS stated that due to the potential endocrine disruptor properties of butylated hydroxytoluene, the maximum safe concentration of this ingredient in mouthwash and toothpaste is 0.001% and 0.1% respectively, and the maximum safe concentration in other types of cosmetics is 0.8%.

[0006] At present, the pharmacopoeias of various countries do not include the quality control methods for ethylparaben and BHT in tretinoin cream. Moreover, the methods for simultaneously detecting ethylparaben and BHT in tretinoin cream are rarely reported. Summary of the invention

[0007] The purpose of the present invention is to provide a high performance liquid chromatography analysis method for simultaneously detecting ethylparaben and BHT in tretinoin cream.

[0008] The present invention provides a high performance liquid chromatography analysis method for detecting ethylparaben and BHT in tretinoin cream, the method comprising the steps of:

[0009] (i) providing a sample;

[0010] (ii) injecting the sample into a high performance liquid chromatograph for analysis to obtain chromatographic analysis data;

[0011] HPLC chromatographic conditions:

[0012] Chromatographic column: Agilent ZORBAXEclipse XDB Phenyl 4.6×150mm, 5μm;

[0013] Mobile phase A: 0.02%-0.2% formic acid in water;

[0014] Mobile phase B: 0.02%-0.2% formic acid acetonitrile solution;

[0015] Column temperature: 30-40°C;

[0016] Flow rate: 0.8-1.2ml / min;

[0017] Detection wavelength: 280±5nm;

[0018] Elution procedure:

[0019] Time (min) A% B% 0 70 30 8 40 60 12 10 90 20 10 90 20.1 70 30 25 70 30 .

[0020] In another preferred embodiment, the mobile phase A is a 0.1% formic acid aqueous solution, and the mobile phase B is a 0.1% formic acid acetonitrile solution.

[0021] In another preferred embodiment, the sample pretreatment method comprises the steps of: quantitatively dissolving vitamin A cream in methanol, ultrasonically extracting and filtering, and taking the filtrate as a sample.

[0022] In another preferred embodiment, the injection volume of the sample is 5 μl to 20 μl.

[0023] In another preferred embodiment, the column temperature is 35°C.

[0024] In another preferred embodiment, the flow rate is 1.0 mL / min.

[0025] In another preferred example, the detection wavelength is 280 nm.

[0026] In another preferred embodiment, the method further comprises the step of: using a standard sample to perform qualitative analysis on the sample by retention time.

[0027] In another preferred embodiment, the method further comprises the step of: using a standard sample to establish an external standard curve by the method, so as to quantitatively analyze the concentration of the analyte in the sample to be tested.

[0028] In another preferred embodiment, the dilution solution of the sample is methanol.

[0029] In another preferred embodiment, the sample pretreatment method includes the following method: take vitamin A cream (such as 0.5-2) g, accurately weigh, place in a volumetric bottle (such as 50mL-500mL), add methanol, shake to disperse, ultrasonicate for 10-30min, dilute to the scale with methanol, shake well, filter, and take the filtrate.

[0030] In another preferred embodiment, the tretinoin cream is a common tretinoin cream on the market. For example, tretinoin cream containing tretinoin (all-trans retinoic acid), other therapeutic agents and common pharmaceutically acceptable carriers for creams can use the method of the present invention to detect whether it contains ethylparaben, BHT, and their content.

[0031] In another preferred embodiment, the other therapeutic agents may include one or more selected from the following group: diphenhydramine hydrochloride.

[0032] In another preferred embodiment, the pharmaceutically acceptable carrier for the cream may include one or more selected from the following groups: vaseline, glyceryl monostearate and distearate, stearic acid, ethyl hydroxybenzoate, light liquid paraffin, lauryl nitrogen Ketones, glycerin, polysorbates, stearyl alcohol, BHT, or a combination thereof.

[0033] In another preferred embodiment, the method includes the following chromatographic conditions:

[0034] Chromatographic column model: Agilent ZORBAX Eclipse XDB Phenyl 4.6×150mm, 5μm;

[0035] Mobile phase A: 0.1% formic acid in water;

[0036] Mobile phase B: 0.1% formic acid in acetonitrile;

[0037] Column temperature: 35°C;

[0038] Flow rate: 1.0 ml / min;

[0039] Detector: PDA;

[0040] Wavelength: 280nm;

[0041] Injection volume: 5 μl

[0042] Elution procedure:

[0043]

[0044]

[0045] In another preferred embodiment, the sample pretreatment method includes the steps of accurately weighing about 1.0 g of retinoic acid cream, placing it in a 50 ml volumetric bottle, adding an appropriate amount of methanol, shaking to disperse, ultrasonicating for 20 minutes, diluting to the scale with methanol, shaking well, filtering, and taking the filtrate.

[0046] It should be understood that within the scope of the present invention, the above-mentioned technical features of the present invention and the technical features specifically described below (such as embodiments) can be combined with each other to form a new or preferred technical solution. Due to space limitations, they will not be described one by one here. BRIEF DESCRIPTION OF THE DRAWINGS

[0047] Figure 1 A chromatogram of a blank solution detected using the method of the present invention;

[0048] Figure 2 A chromatogram of a control solution detected using the method of the present invention;

[0049] Figure 3 The present invention is used to detect a chromatogram of a test sample solution. DETAILED DESCRIPTION

[0050] The inventor has provided a high performance liquid chromatography analysis method for detecting ethylparaben and BHT in tretinoin cream through extensive and in-depth research, through a large number of screenings and tests. The method of the present invention can realize the separation of tretinoin from ethylparaben and BHT, and provides a basis for the quality control of ethylparaben and BHT in tretinoin cream. Experiments have shown that the method can meet the requirements of specificity, linearity, sensitivity, accuracy, repeatability and durability. The present invention has been completed on this basis.

[0051] the term

[0052] Unless defined otherwise, all technical and scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the art to which this invention belongs.

[0053] As used herein, the term "comprising" or "including (comprising)" may be open, semi-closed and closed. In other words, the term also includes "consisting essentially of" or "consisting of".

[0054] As used herein, the term "room temperature" or "normal temperature" refers to a temperature of 4-40°C, preferably, 25±5°C.

[0055] HPLC analysis method

[0056] The present invention provides a high performance liquid chromatography analysis method for detecting ethylparaben and BHT in tretinoin cream, characterized in that the method comprises the steps of:

[0057] (i) providing a sample;

[0058] (ii) injecting the sample into a high performance liquid chromatograph for analysis to obtain chromatographic analysis data;

[0059] HPLC chromatographic conditions:

[0060] Chromatographic column: Agilent ZORBAXEclipse XDB Phenyl 4.6×150mm, 5μm;

[0061] Mobile phase A: 0.02%-0.2% formic acid in water;

[0062] Mobile phase B: 0.02%-0.2% formic acid acetonitrile solution;

[0063] Column temperature: 30-40°C;

[0064] Flow rate: 0.8-1.2ml / min;

[0065] Detection wavelength: 280±5nm;

[0066] Elution procedure:

[0067] Time (min) A% B% 0 70 30 8 40 60 12 10 90 20 10 90 20.1 70 30 25 70 30 .

[0068] In another preferred embodiment, the mobile phase A is a 0.1% formic acid aqueous solution, and the mobile phase B is a 0.1% formic acid acetonitrile solution.

[0069] In another preferred embodiment, the sample pretreatment method comprises the steps of: quantitatively dissolving vitamin A cream in methanol, ultrasonically extracting and filtering, and taking the filtrate as a sample.

[0070] In another preferred embodiment, the injection volume of the sample is 5 μl to 20 μl.

[0071] In another preferred embodiment, the column temperature is 35°C.

[0072] In another preferred embodiment, the flow rate is 1.0 mL / min.

[0073] In another preferred example, the detection wavelength is 280 nm.

[0074] In another preferred embodiment, the method further comprises the step of: using a standard sample to perform qualitative analysis on the sample by retention time.

[0075] In another preferred embodiment, the method further comprises the step of: using a standard sample to establish an external standard curve by the method, so as to quantitatively analyze the concentration of the analyte in the sample to be tested.

[0076] In another preferred embodiment, the dilution solution of the sample is methanol.

[0077] In another preferred embodiment, the sample pretreatment method includes the following method: take vitamin A cream (such as 0.5-2) g, accurately weigh, place in a volumetric bottle (such as 50mL-500mL), add methanol, shake to disperse, ultrasonicate for 10-30min, dilute to the scale with methanol, shake well, filter, and take the filtrate.

[0078] In another preferred embodiment, the tretinoin cream is a common tretinoin cream on the market. For example, tretinoin cream containing tretinoin (all-trans retinoic acid), other therapeutic agents and common pharmaceutically acceptable carriers for creams can use the method of the present invention to detect whether it contains ethylparaben, BHT, and their content.

[0079] In another preferred embodiment, the other therapeutic agents may include one or more selected from the following group: diphenhydramine hydrochloride.

[0080] In another preferred embodiment, the pharmaceutically acceptable carrier for the cream may include one or more selected from the following groups: vaseline, glyceryl monostearate and distearate, stearic acid, ethyl hydroxybenzoate, light liquid paraffin, lauryl nitrogen Ketones, glycerin, polysorbates, stearyl alcohol, BHT, or a combination thereof.

[0081] More specifically, the method of the present invention comprises the following chromatographic conditions,

[0082] Chromatographic column model: Agilent ZORBAX Eclipse XDB Phenyl 4.6×150mm, 5μm;

[0083] Mobile phase A: 0.1% formic acid in water;

[0084] Mobile phase B: 0.1% formic acid in acetonitrile;

[0085] Column temperature: 35°C;

[0086] Flow rate: 1.0 ml / min;

[0087] Detector: PDA;

[0088] Wavelength: 280nm;

[0089] Injection volume: 5 μl

[0090] Elution procedure:

[0091]

[0092]

[0093] The method for preparing the test solution includes: accurately weighing about 1.0 g of retinoic acid cream, placing it in a 50 ml volumetric flask, adding an appropriate amount of methanol, shaking to disperse, ultrasonicating for 20 minutes, diluting to the scale with methanol, shaking well, filtering, and taking the filtrate.

[0094] The main advantages of the present invention include:

[0095] The invention provides a high performance liquid chromatography analysis method for detecting ethylparaben and BHT in tretinoin cream. The method can separate tretinoin from ethylparaben and BHT, and provide a basis for quality control of ethylparaben and BHT in tretinoin cream. Experiments show that the method can meet the requirements of specificity, linearity, sensitivity, accuracy, repeatability and durability.

[0096] The present invention will be further described below in conjunction with specific implementation. It should be understood that these embodiments are only used to illustrate the present invention and are not intended to limit the scope of the present invention. The experimental methods in the following examples without specifying specific conditions are usually based on conventional conditions or the conditions recommended by the manufacturer. Unless otherwise stated, percentages and parts are calculated by weight.

[0097] After screening, the following chromatographic conditions were obtained and the method was investigated:

[0098] Column model: Agilent ZORBAX Eclipse XDB Phenyl 4.6×150mm, 5μm;

[0099] Mobile phase A: 0.1% formic acid in water;

[0100] Mobile phase B: 0.1% formic acid in acetonitrile;

[0101] Column temperature: 35°C;

[0102] Flow rate: 1.0 ml / min;

[0103] Detector: PDA;

[0104] Wavelength: 280nm;

[0105] Injection volume: 5 μl

[0106] Elution procedure:

[0107]

[0108]

[0109] Solution preparation:

[0110] Blank solution: methanol.

[0111] Preparation of reference solution: accurately weigh about 40 mg of ethylparaben reference substance and about 12 mg of BHT reference substance, place them in the same 100 ml volumetric flask, dissolve them with methanol and dilute to the mark; accurately measure 1 ml of the above solution and place it in a 10 ml volumetric flask, dissolve them with methanol and dilute to the mark to prepare a solution containing about 40 μg / ml of ethylparaben and about 12 μg / ml of BHT.

[0112] Test solution: Take retinoic acid cream (treatment: retinoic acid 0.1%, diphenhydramine hydrochloride 0.3%, white vaseline 1.0%, mono- and distearic glyceryl 10.0%, stearic acid 1.0%, ethyl hydroxybenzoate 0.2%, light liquid paraffin 5.12%, lauryl nitrogen Accurately weigh about 1.0 g of 1,4-dimethoxy-2-nitropropene (1.00%, glycerol: 5.0%, polysorbate 80: 0.3%, octadecyl alcohol: 3.12%, BHT: 0.06%, purified water: 72.8%), place in a 50 ml volumetric flask, add appropriate amount of methanol, shake to disperse, ultrasonicate for 20 min, dilute to the scale with methanol, shake well, filter, and take the filtrate.

[0113] The above test solution preparation process was repeated, and acetonitrile and tetrahydrofuran were used as solvents instead of methanol for pretreatment. The spiked recoveries of ethyl 4-hydroxybenzoate and BHT were investigated. The results are shown in Table 1.

[0114] Table 1

[0115]

[0116]

[0117] Results: When methanol was used as solvent for pretreatment, the horizontal recovery rates of each component were between 94% and 106%; when acetonitrile was used as solvent for pretreatment, the recovery rates of each component were between 80% and 88%, which was on the low side; when tetrahydrofuran was used as solvent for pretreatment, the spiked recovery rates of ethyl hydroxybenzoate were between 96% and 101%, and the recovery rates of BHT were between 64% and 87%. It can be seen that using methanol as solvent has higher accuracy.

[0118] Calculation method: Calculate the content of ethylparaben and BHT in the test sample according to the external standard method.

[0119] 1. System suitability investigation

[0120] The reference solution was injected 6 times continuously to examine the injection precision.

[0121] Results: The reference solution was injected 6 times continuously. The RSDs of retention time of ethylparaben and BHT were 0.08% and 0.1%, respectively. The RSDs of peak area of ​​ethylparaben and BHT were 0.8% and 0.9%.

[0122] 2. Exclusive inspection

[0123] Take blank solution, reference solution and test solution and inject them separately for specificity investigation.

[0124] result:

[0125] There was no interference in the blank and test solutions. The separation degree between ethylparaben and BHT in the reference solution was 60.2. The minimum separation degree between ethylparaben, BHT and retinoic acid in the test solution was 7.8, which met the separation requirements.

[0126] 3. Sensitivity test

[0127] Dilute the mixed solution of ethylparaben and BHT step by step, confirm the detection limit and quantification limit of each component, and take the quantification limit solution for 6 consecutive injections. The signal-to-noise ratio of the quantification limit should be no less than 10, and the signal-to-noise ratio of the detection limit should be no less than 3.

[0128] The results are shown in Table 2:

[0129] Table 2

[0130]

[0131]

[0132] 4. Linear

[0133] A series of mixed solutions of ethylparaben and BHT were prepared and injected respectively. Linear curves were drawn between the peak areas at different concentrations and the corresponding concentrations to obtain the linear equations of ethylparaben and BHT.

[0134] Table 3

[0135]

[0136] The results are shown in Table 3. Ethylparaben and BHT showed a good linear relationship in the range of 0.5-200 μg / ml.

[0137] 5. Repeatability test

[0138] Take 6 minutes of the test solution and inject it continuously, record the chromatogram, and calculate the content of ethylparaben and BHT by the external standard method.

[0139] The results are shown in Table 4:

[0140] Table 4

[0141]

[0142] 6. Accuracy test

[0143] The spike recovery experiment was carried out using retinoic acid cream without ethylparaben and BHT as blank sample. Three concentration levels of ethylparaben and BHT were added to investigate their spike recovery rates.

[0144] Table 5

[0145]

[0146] The results are shown in Table 4. In the blank sample, neither ethylparaben nor BHT was detected, and the recovery rates at each addition level were between 94% and 106%, which were within the error range of the detection.

[0147] 5. Durability inspection

[0148] The chromatographic parameters of column temperature (35±5℃), flow rate (1.0±0.2ml / min), wavelength (280±5nm), and formic acid content (0.02% and 0.2%) were adjusted, and the reference solution and the test solution were injected separately. The injection precision of the reference solution, the minimum separation of retinoic acid, ethylparaben and BHT in the test solution, and the contents of ethylparaben and BHT were compared under different parameter conditions.

[0149] Table 6

[0150]

[0151]

[0152] The results are shown in Table 5, which indicate that the method can meet the detection requirements for various impurities within the parameter range of column temperature 35±5°C, flow rate 1.0±0.2ml / min, wavelength 280±5nm, and formic acid percentage 0.02-0.2%.

[0153] In summary, the method of the present invention can meet the requirements of specificity, linearity, sensitivity, accuracy, repeatability and durability, and can be used for the simultaneous qualitative and quantitative detection of ethylparaben and BHT in tretinoin cream.

[0154] All documents mentioned in the present invention are cited as references in this application, just as each document is cited as reference individually. In addition, it should be understood that after reading the above teachings of the present invention, those skilled in the art can make various changes or modifications to the present invention, and these equivalent forms also fall within the scope defined by the claims attached to this application.

Claims

1. A high performance liquid chromatography analysis method for detecting ethylparaben and BHT in tretinoin cream, It is characterized in that The method comprises the steps of: (i) providing a sample; (ii) injecting the sample into a high performance liquid chromatograph for analysis to obtain chromatographic analysis data; HPLC chromatographic conditions: Chromatographic column: Agilent ZORBAXEclipse XDB Phenyl 4.6×150mm, 5μm; Mobile phase A: 0.02%-0.2% formic acid in water; Mobile phase B: 0.02%-0.2% formic acid acetonitrile solution; Column temperature: 30-40°C; Flow rate: 0.8-1.2ml / min; Detection wavelength: 280±5nm; Elution procedure: 。 2. The method according to claim 1, It is characterized in that The mobile phase A was a 0.1% formic acid aqueous solution, and the mobile phase B was a 0.1% formic acid acetonitrile solution.

3. The method according to claim 1, It is characterized in that The sample pretreatment method comprises the steps of quantitatively dissolving vitamin A cream in methanol, ultrasonically extracting and filtering, and taking the filtrate as a sample.

4. The method according to claim 1, It is characterized in that The flow rate was 1.0 mL / min.

5. The method according to claim 1, It is characterized in that The detection wavelength is 280 nm.

6. The method according to claim 1, It is characterized in that The column temperature was 35°C.

7. The method according to claim 1, It is characterized in that The method further comprises the step of using a standard sample to perform qualitative analysis on the sample by retention time.

8. The method according to claim 1, It is characterized in that The method further comprises the step of: using a standard sample to establish an external standard curve through the method, thereby quantitatively analyzing the concentration of the analyte in the sample to be tested.

9. The method according to claim 1, It is characterized in that The sample pretreatment method includes the following steps: taking vitamin A cream (such as 0.5-2) g, accurately weighing, placing in a volumetric bottle (such as 50mL-500mL), adding methanol, shaking to disperse, ultrasonicating for 10-30min, diluting to the scale with methanol, shaking well, filtering, and taking the filtrate.

10. The method according to claim 1, It is characterized in that The method comprises the following chromatographic conditions, Chromatographic column model: Agilent ZORBAX Eclipse XDB Phenyl 4.6×150mm, 5μm; Mobile phase A: 0.1% formic acid in water; Mobile phase B: 0.1% formic acid in acetonitrile; Column temperature: 35°C; Flow rate: 1.0 ml / min; Detector: PDA; Wavelength: 280nm; Injection volume: 5 μl Elution procedure: 。

Citation Information

Cited By

  • Method and system for detecting contents of main drugs and auxiliary materials in isotretinoin gel

    CN120870407A